Surprisingly, canonical tumor suppressors and oncogenes regarded as most frequently mutated were not among the top hits in the medium and high MLGs; in fact, in the high MLG TP53 ranked 65th, with a normalized mutation ∼4- to 10-fold lower than the top hits, where several protocadherin genes were included (Figure 10B). This evidence concerns the gene TP53 and neoplasm.